Business
Press Release Jan 04 2021
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled "Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis".
About this update from Sun Pharmaceutical Industries Limited
[{"type":"text","content":" Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 04, 2021, titled \"Sun Pharma announces initiation of Phase 2 Clinical Trial of SCD-044 in Patients with Moderate to Severe Plaque Psoriasis\". View Attachment","length":399,"tagName":"div"}]